Advertisement
News
Advertisement

Millennium reports myeloma drug advances, updates drug recalls

Mon, 12/12/2011 - 6:48pm
Mass High Tech: The Journal of New England Technology

Cambridge cancer pharmaceutical company Millennium: The Takeda Oncology is reporting advances in its drugs for multiple myeloma, and said it is adding manufacturing suppliers in the wake of a series of precautionary recalls for its Velcade treatment in the United States and Europe.

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading